Drinking two small glasses of cherry juice a day may reduce gut inflammation and boost quality of life in bowel disease ...

In a phase 2 trial, lusvertikimab significantly improves clinical and endoscopic outcomes in patients with moderate to severe ...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules <li /> Key biosimilar value driver contributes to Sandoz global ...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Key biosimilar value driver contributes to Sandoz global growth strategy and moves company closer to becoming #1 in biosimilars ...

Johnson & Johnson (NYSE: JNJ) has announced positive results from the Phase 3 ASTRO study evaluating TREMFYA® (guselkumab) ...

The timing of surgery remains a cardinal decision in the management of severe ulcerative colitis; increased morbidity resulting from prolonged ineffective medical treatment and, therefore ...

“This could influence treatment decisions and improve respiratory health in this high-risk population.” “GLP-1 medications might help lower COPD exacerbation risk by reducing systemic ...

H.I.V. treatment and services were funded through the President’s Emergency Plan for AIDS Relief, or PEPFAR, a $7.5 billion program that was frozen along with all foreign aid on Mr. Trump’s ...

A 28-year study on the serious inflammatory bowel disease, acute severe ulcerative colitis (UC) has resulted in an innovative artificial intelligence tool called the Risk of Rescue (ROR) score. This ...